Analysen zu Novartis AG
| 29.10.24 | Novartis Buy | UBS AG | |
| 29.10.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 08.10.24 | Novartis Hold | Deutsche Bank AG | |
| 02.10.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 18.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 11.09.24 | Novartis Buy | UBS AG | |
| 05.09.24 | Novartis Neutral | Goldman Sachs Group Inc. | |
| 03.09.24 | Novartis Hold | Jefferies & Company Inc. | |
| 23.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 19.07.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 19.07.24 | Novartis Kaufen | DZ BANK | |
| 19.07.24 | Novartis Hold | Deutsche Bank AG | |
| 19.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 19.07.24 | Novartis Buy | UBS AG | |
| 18.07.24 | Novartis Outperform | Bernstein Research | |
| 18.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 18.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 10.07.24 | Novartis Buy | Deutsche Bank AG | |
| 03.07.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 02.07.24 | Novartis Buy | Jefferies & Company Inc. | |
| 02.07.24 | Novartis Buy | Deutsche Bank AG | |
| 01.07.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.06.24 | Novartis Underweight | Barclays Capital | |
| 11.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 05.06.24 | Novartis Buy | Deutsche Bank AG | |
| 03.06.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 03.06.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 03.06.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | UBS AG | |
| 31.05.24 | Novartis Buy | Jefferies & Company Inc. | |
| 30.05.24 | Novartis Buy | Goldman Sachs Group Inc. | |
| 24.05.24 | Novartis Buy | Deutsche Bank AG | |
| 23.05.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 06.05.24 | Novartis Buy | UBS AG | |
| 26.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 24.04.24 | Novartis Buy | UBS AG | |
| 24.04.24 | Novartis Buy | Deutsche Bank AG | |
| 24.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 23.04.24 | Novartis Underweight | Barclays Capital | |
| 23.04.24 | Novartis Buy | UBS AG | |
| 23.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 18.04.24 | Novartis Buy | UBS AG | |
| 18.04.24 | Novartis Buy | Deutsche Bank AG | |
| 10.04.24 | Novartis Buy | UBS AG | |
| 04.04.24 | Novartis Buy | Jefferies & Company Inc. | |
| 04.04.24 | Novartis Buy | UBS AG | |
| 03.04.24 | Novartis Neutral | JP Morgan Chase & Co. | |
| 28.03.24 | Novartis Underweight | Barclays Capital | |
| 25.03.24 | Novartis Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) |
Aktuelle Aktienanalysen
| 14.04.25 | L'Oréal Outperform | RBC Capital Markets | |
| 14.04.25 | L'Oréal Hold | Jefferies & Company Inc. | |
| 14.04.25 | SAP Buy | Jefferies & Company Inc. | |
| 14.04.25 | Rolls-Royce Buy | Jefferies & Company Inc. | |
| 14.04.25 | SAFRAN Buy | Jefferies & Company Inc. | |
| 14.04.25 | Airbus Hold | Jefferies & Company Inc. | |
| 14.04.25 | MTU Aero Engines Buy | Jefferies & Company Inc. | |
| 14.04.25 | MTU Aero Engines Buy | Jefferies & Company Inc. | |
| 14.04.25 | JPMorgan Chase Halten | DZ BANK | |
| 14.04.25 | JOST Werke Buy | Warburg Research | |
| 14.04.25 | HUGO BOSS Buy | Warburg Research | |
| 14.04.25 | Polytec buy | Baader Bank | |
| 14.04.25 | Beiersdorf Sell | Deutsche Bank AG | |
| 14.04.25 | DHL Group Buy | Jefferies & Company Inc. | |
| 14.04.25 | Dürr Buy | Warburg Research | |
| 14.04.25 | DocMorris Hold | Warburg Research | |
| 14.04.25 | voestalpine buy | Deutsche Bank AG | |
| 14.04.25 | Pernod Ricard Neutral | UBS AG | |
| 14.04.25 | Diageo Buy | UBS AG | |
| 14.04.25 | AB InBev Buy | UBS AG | |
| 14.04.25 | Gerresheimer Buy | Deutsche Bank AG | |
| 14.04.25 | Ferrari Buy | UBS AG | |
| 14.04.25 | Volkswagen Neutral | UBS AG | |
| 14.04.25 | Valeo Neutral | UBS AG | |
| 14.04.25 | Schaeffler Neutral | UBS AG | |
| 14.04.25 | Renault Neutral | UBS AG | |
| 14.04.25 | Porsche Neutral | UBS AG | |
| 14.04.25 | Michelin Buy | UBS AG | |
| 14.04.25 | Mercedes-Benz Group Neutral | UBS AG | |
| 14.04.25 | Continental Buy | UBS AG | |
| 14.04.25 | BMW Buy | UBS AG | |
| 14.04.25 | Apple Overweight | JP Morgan Chase & Co. | |
| 14.04.25 | Saint-Gobain Hold | Deutsche Bank AG | |
| 14.04.25 | Gerresheimer Buy | Hauck Aufhäuser Lampe Privatbank AG | |
| 14.04.25 | Santander Overweight | Barclays Capital | |
| 14.04.25 | BBVA Equal Weight | Barclays Capital | |
| 14.04.25 | Stellantis Neutral | UBS AG | |
| 14.04.25 | ArcelorMittal Buy | Deutsche Bank AG | |
| 14.04.25 | Salzgitter Hold | Deutsche Bank AG | |
| 14.04.25 | Salzgitter Buy | Baader Bank | |
| 14.04.25 | Roche Buy | UBS AG | |
| 14.04.25 | Richemont Buy | UBS AG | |
| 14.04.25 | L'Oréal Overweight | Barclays Capital | |
| 14.04.25 | Symrise Hold | Jefferies & Company Inc. | |
| 14.04.25 | KWS SAAT Buy | Jefferies & Company Inc. | |
| 14.04.25 | K+S Underperform | Jefferies & Company Inc. | |
| 14.04.25 | Givaudan Underperform | Jefferies & Company Inc. | |
| 14.04.25 | Evonik Underperform | Jefferies & Company Inc. | |
| 14.04.25 | Brenntag Hold | Jefferies & Company Inc. | |
| 14.04.25 | BASF Buy | Jefferies & Company Inc. |
ETF-Sparplan
Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.